Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,125 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

NCT00384904

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Garden State Infectious Disease Associates, Pa Voorhees Township, New Jersey, United States
  • Unc Center For Aids Research Chapel Hill, North Carolina, United States
  • Local Institution Philadelphia, Pennsylvania, United States
  • Local Institution London, Greater London, United Kingdom
View Trial Details
Completed

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

NCT00135395

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Local Institution Hobson City, Alabama, United States
  • Local Institution Montgomery, Alabama, United States
  • Local Institution Phoenix, Arizona, United States
  • Local Institution Little Rock, Arkansas, United States
View all 53 locations
View Trial Details
Completed

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

NCT00120393

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Local Institution Phoenix, Arizona, United States
  • Local Institution Bakersfield, California, United States
  • Local Institution Los Angeles, California, United States
  • Local Institution San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

DDI HV (ATV - Merck)

NCT00518297

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States
View Trial Details
Completed

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

NCT00340080

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • GSK Investigational Site Darlinghurst, New South Wales, Australia
  • GSK Investigational Site Miami, Queensland, Australia
  • GSK Investigational Site Graz, Austria
  • GSK Investigational Site Innsbruck, Austria
View all 254 locations
View Trial Details
Completed

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

NCT00511368

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Quest Clinical Research San Francisco, California, United States
  • University of Colorado Health Science Center Denver, Colorado, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
View all 18 locations
View Trial Details

Related conditions